# A Study of HM10560A in Healthy Male Subject

> **NCT01093742** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HM10560A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01093742
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093742, "A Study of HM10560A in Healthy Male Subject". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01093742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
